InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Monksdream PremiumMember
09/08/24 12:54 PM
profile icon
Monksdream PremiumMember
07/04/24 10:25 AM
profile icon
tw0122 Free
05/07/24 10:41 AM
profile icon
Monksdream PremiumMember
04/28/24 6:33 PM
profile icon
bikaver Free
11/01/23 6:06 PM
Bullish
Bullish
profile icon
bikaver Free
09/29/23 5:14 PM
profile icon
bikaver Free
09/21/23 5:13 PM
profile icon
Stockexpertpro Free
09/21/23 8:39 AM
Bearish
Bearish
profile icon
alchemytrader Free
08/17/21 7:56 PM
profile icon
cash4 Free
02/05/21 12:12 AM

Travere Therapeutics, Inc. (TVTX) RSS Feed

Followers
2
Posters
6
Posts (Today)
0
Posts (Total)
10
Created
02/04/21
Type
Free
Moderators
 

TVTX

Travere Therapeutics, Inc.

 
DESCRIPTION
Retrophin, Inc. (OTCQB: RTRX) New York-based, biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. Retrophin is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy (DMD), and Spinal Muscular Atrophy (SMA).
 
 
TVTX SECURITY DETAILS

Share Structure

 
 
Market Cap Market Cap
1,547,540,059
02/03/2021
Authorized Shares
100,000,000
03/05/2013
Outstanding Shares
50,905,923
07/29/2020
Restricted
Not Available
 
Unrestricted
Not Available
 
Held at DTC
Not Available
 
Float
8,280,000
03/05/2013
Par Value
0.0001
 

TRAVERE THERAPEUTICS, INC.

3611 Valley Centre Drive

Suite 300

San Diego, CA 92130

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post